Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Journal of Cancer
1000-467X
2013 Issue 7
Targeted therapy: tailoring cancer treatment
Min Yan 1;2 and Quentin Qiang Liu 1;2;3 1 State Key Laboratory of Oncology in South China;Guangzhou;Guangdong 510060;P. R. China;2 Research Department;Sun Yat-sen University Cancer Center;Guangzhou;Guangdong 510060;P. R. China;3 Institute of Cancer Stem Cell;Cancer Center;Dalian Medical University;Dalian;Liaoning 116044;P. R. China.
..............page:363-364
Information for Authors
..............page:419
Overexpression of Cdc25C predicts response to radiotherapy and survival in esophageal squamous cell carcinoma patients treated with radiotherapy followed by surgery
Bao-Zhong Li 1;Zhao-Li Chen 1;Su-Sheng Shi 2;Xiao-Li Feng 2;Xiao-Gang Tan 1;Fang Zhou 1 and Jie He 1 Departments of 1 Thoracic Surgery and 2 Pathology;Cancer Hospital;Peking Union Medical College & Chinese Academy of Medical Sciences;Beijing 100021;P.R.China.
..............page:403-409
Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance
Ana R.Gomes;Fung Zhao and Eric W.F.Lam Department of Surgery and Cancer;Imperial College London;Hammersmith Hospital Campus;London;W12 0NN;United Kingdom.
..............page:365-370
Skeletal metastasis:treatments,mouse models,and the Wnt signaling
Kenneth C.Valkenburg 1;Matthew R.Steensma 1;2;Bart O.Williams 1 and Zhendong Zhong 1 1 Center for Skeletal Disease Research;Van Andel Research Institute;333 Bostwick Ave.NE;Grand Rapids;MI 49503;USA;2 Orthopedic Oncology;Spectrum Health;145 Michigan St.NE;Grand Rapids;MI 49503;USA.
..............page:380-396
Translational Research in Oncology Research & Development and Its Impact on Early Development in China: report of the 5th Annual Meeting of the US Chinese Anti-Cancer Association (USCACA) at 2013 AACR Annual Meeting
Lingjie Guan 1;Yun Dai 1;2 and Roger Luo 1 1 Executive Committee of the US Chinese Anti-Cancer Association;2 Department of Medicine;Virginia Commonwealth University and the Massey Cancer Center;234 Goodwin;401 College St.;Richmond;VA 23298;USA.
..............page:357-362
Volumetric modulation arc radiotherapy with flattening filter-free beams compared with conventional beams for nasopharyngeal carcinoma:a feasibility study
Mingzan Zhuang 1;Tuodan Zhang 1;Zhijian Chen 1;Zhixiong Lin 1;Derui Li 1;Xun Peng 1;Qingchun Qiu 2 and Renhua Wu 3 1 Department of Radiation Oncology;Tumor Hospital of Shantou University Medical College;Shantou;Guangdong 515000;P.R.China;2 Department of Medical Physics and Computer Application;Shantou University Medical College;Shantou;Guangdong 515000;P.R.China;3 Department of Radiation;The Second Affiliated Hospital of Shantou University Medical College;Shantou;Guangdong 515000;P.R.China.
..............page:397-402
Molecular mechanisms of tumor resistance to PI3K-mTOR-targeted therapy
Jing Tan 1 and Qiang Yu 1;2;3 1 Cancer Therapeutics and Stratified Oncology;Genome Institute of Singapore;A*STAR;Biopolis;Singapore 138672;Singapore;2 Department of Physiology;Yong Loo Lin School of Medicine;National University of Singapore;Singapore 117599;Singapore;3 Cancer and Stem Cell Biology;DUKE-NUS Graduate Medical School of Singapore;Singapore 169857;Singapore.
..............page:376-379
Mouse models of Mdm2 and Mdm4 and their clinical implications
Shunbin Xiong Department of Genetics;The University of Texas M.D.Anderson Cancer Center;1515 Holcombe Boulevard;Houston;TX 77030;USA.
..............page:371-375
Malignant meningioma of the cerebellopontine angle in a 2-year-old girl:a case report and literature review
Ming-Chao Fan 1;Xin Zhang 2;Qiao-Ling Wang 3;Lei Cheng 2;Cai-Yun Dai 2;Dan Yu 2 and Peng Sun 2 1 Department of Neurosurgical Intensive Care Unit;2 Department of Neurosurgery;the Affiliated Hospital of Medical College;Qingdao University;Qingdao;Shandong 266003;P.R.China;3 The Community Medical Service Center of Zhenjiang Road;North City District;Qingdao;Shandong 266024;P.R.China.
..............page:415-417
The absence of the ERBB4 hotspot mutations in melanomas in patients from southern China
Qi-Ming Zhou 1;2;5;Wei Li 6;Yuan-Xiang Guan 1;3;Xing Zhang 1;2;Xin-Chun Chen 6;Ya Ding 1;2;Xi-Zhi Wen 1;2;Rui-Qing Peng 1;2;Shu-Mei Yan 1;4 and Xiao-Shi Zhang 1;2 1 State Key Laboratory of Oncology in South China;Guangzhou;Guangdong 510060;P.R.China;2 Melanoma Unit & Biotherapy Center;3 Department of Gastric and Pancreatic Oncology;4 Department of Pathology;Sun Yat-sen University Cancer Center;Guangzhou;Guangdong 510060;P.R.China;5 Department of Oncology;The Sixth People Hospital of Shenzhen;Shenzhen;Guangdong 518052;P.R.China;6 Institute of Hepatology;The Third People Hospital of Shenzhen;Shenzhen;Guangdong 518020;P.R.China.
..............page:410-414